Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 134.25 percent decrease over earnings of $1.81 per share from the same period last year.
Earnings Outlook For E2open Parent Holdings, Inc.Class A Common Stock
E2open Parent Holdings, Inc.Class A Common Stock (NYSE:ETWO) is set to give its latest quarterly earnings report on Monday, 2022-07-11. Here's what investors need to know before the announcement.
